Search | Page 38 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Shorter Course Tacrolimus After Nonmyeloablative, Related Donor BMT With High-dose Posttransplantation Cyclophosphamide

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

    Clinical Trial last updated 05/02/2016 - 2:38pm.

  2. PRO#1278: Fludarabine and Busulfan vs. Fludarabine, Busulfan and Total Body Irradiation (FLUBUTBI)

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... illness likely to interfere with participation in this clinical study   Donor Exclusion Criteria Identical twin Female ...

    Clinical Trial last updated 04/29/2016 - 3:09pm.

  3. Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... Any medical condition which, in the opinion of the clinical investigator, would interfere with the evaluation of the patient. ...

    Clinical Trial last updated 04/29/2016 - 4:33pm.

  4. Extended Dosing With Eltrombopag for Severe Aplastic Anemia

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... (HCV)-infection. Eltrombopag has been well-tolerated in clinical trials, and unlike recombinant TPO, it does not induce autoantibodies. ...

    Clinical Trial last updated 04/26/2016 - 9:36am.

  5. Four Essentials in Setting the Stage for Patient Understanding of MDS, Aplastic Anemia, or PNH

    ... , aplastic anemia , and PNH for 16 years. She is a Clinical Research Coordinator at the University of Florida and has recently completed a Master’s of Science in Clinical Research. Mrs. Pettiford thanks her patients for being incredible ... routine treatment or participation in a clinical trial , all patients must be given adequate time to comprehend the ...

    Page last updated 07/25/2014 - 10:18am.

  6. Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematologic Malignancies.

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

    Clinical Trial last updated 04/29/2016 - 3:51pm.

  7. Lenalidomide After Allo-Hematopoietic Cell Transplant (HCT) in Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndromes (MDS) Subjects With Minimal Residual Disease (UF-BMT-MRD-101)

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

    Clinical Trial last updated 04/29/2016 - 2:38pm.

  8. Safety and Tolerability of HSC835 in Patients With Hematological Malignancies

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

    Clinical Trial last updated 04/29/2016 - 2:14pm.

  9. The Rapid Study: Randomized Phase II Study To Expedite Allogeneic Transplant With Immediate Haploidentical Plus Unrelated Cord Donor Search Versus Matched Unrelated Donor Search For AML And High-Risk MDS Patients

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

    Clinical Trial last updated 04/29/2016 - 2:02pm.

  10. KIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT Children

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

    Clinical Trial last updated 04/29/2016 - 2:01pm.